European CHMP Issues Positive Opinion On Cymbalta For The Treatment Of Generalised Anxiety Disorder

Posted by poster | Uncategorized | Saturday 12 July 2008 11:35 pm

Eli Lilly and Co (NYSE: LLY) and Boehringer Ingelheim announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion supporting the approval of Cymbalta® (duloxetine hydrochloride) for the treatment of Generalised Anxiety (more…)

Food Allergies On A Stick: The Risks Of Summer Eating

Posted by poster | Uncategorized | Saturday 12 July 2008 11:35 pm

Most people would rather not know what goes into the corndog they consume at the summer carnival.
But for the 12 million Americans with food allergies, awareness of ingredients is a must for safely eating their way through summer events, according to the American Academy of Allergy, Asthma & Immunology (AAAAI).
"People with food allergies must be extra vigilant when eating at summer (more…)

Predictors of personal stigma among those with high levels of depressive symptoms

Posted by poster | Uncategorized | Friday 11 July 2008 10:35 pm

Men’s Health News
Personal
stigma associated with depression is higher among men and the less well educated, according to research published in the open access journal BMC Psychiatry. The findings by the Australian team highlight the importance of developing programs to tackle the stigma associated with depression.
Researchers from the Australian National University examined both personal stigma, which is the (more…)

Breaking Down The Barriers To Good Asthma Care

Posted by poster | Uncategorized | Friday 11 July 2008 10:35 pm

Asthma UK is launching a set of new healthcare booklets which will help people from South Asian communities, who have been admitted to hospital with a potentially life-threatening asthma attack, avoid future emergency admissions.
There are over 200 emergency admissions for asthma a day in the UK and people from South Asian communities are three times more likely than white (more…)

New Data Demonstrate Efficacy Of Aerius(R) (Desloratadine) In Reducing Allergy Symptoms In Patients With Intermittent Allergic Rhinitis

Posted by poster | Uncategorized | Thursday 10 July 2008 9:36 pm

New data presented at the XXVII Congress of the European Academy of Allergology and Clinical Immunology (EAACI) in Barcelona, Spain, demonstrate AERIUS® (desloratadine) significantly reduces allergy symptoms, including nasal congestion, sneezing, rhinorrhea, nasal pruritus and ocular pruritus, in (more…)

« Previous PageNext Page »